We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSS icon
701
Kohl's
KSS
$2.03B
$3K ﹤0.01%
68
LBTYK icon
702
Liberty Global Class C
LBTYK
$3.25B
$3K ﹤0.01%
110
LDOS icon
703
Leidos
LDOS
$14.1B
$3K ﹤0.01%
+35
New +$2.56K
LECO icon
704
Lincoln Electric
LECO
$13.8B
$3K ﹤0.01%
37
LOPE icon
705
Grand Canyon Education
LOPE
$3.71B
$3K ﹤0.01%
+29
New +$3.46K
LVS icon
706
Las Vegas Sands
LVS
$30.5B
$3K ﹤0.01%
53
+15
+39% +$929
LYB icon
707
LyondellBasell Industries
LYB
$19.5B
$3K ﹤0.01%
33
-20
-38% -$1.71K
MANH icon
708
Manhattan Associates
MANH
$8.97B
$3K ﹤0.01%
48
MGM icon
709
MGM Resorts International
MGM
$11.7B
$3K ﹤0.01%
92
MIDD icon
710
Middleby
MIDD
$6.05B
$3K ﹤0.01%
20
MOO icon
711
VanEck Agribusiness ETF
MOO
$989M
$3K ﹤0.01%
44
MRVL icon
712
Marvell Technology
MRVL
$174B
$3K ﹤0.01%
133
MSM icon
713
MSC Industrial Direct
MSM
$7.02B
$3K ﹤0.01%
38
NBIX icon
714
Neurocrine Biosciences
NBIX
$17.7B
$3K ﹤0.01%
40
NCLH icon
715
Norwegian Cruise Line
NCLH
$8.89B
$3K ﹤0.01%
60
NFG icon
716
National Fuel Gas
NFG
$7.84B
$3K ﹤0.01%
60
NICE icon
717
Nice
NICE
$5.29B
$3K ﹤0.01%
23
-10
-30% -$1.35K
NUE icon
718
Nucor
NUE
$56.4B
$3K ﹤0.01%
56
OMF icon
719
OneMain Financial
OMF
$6.9B
$3K ﹤0.01%
95
OSK icon
720
Oshkosh
OSK
$9.67B
$3K ﹤0.01%
32
PCRX icon
721
Pacira BioSciences
PCRX
$1.02B
$3K ﹤0.01%
73
PHM icon
722
Pultegroup
PHM
$24.5B
$3K ﹤0.01%
104
POWI icon
723
Power Integrations
POWI
$3.54B
$3K ﹤0.01%
70
PSO icon
724
Pearson
PSO
$9.78B
$3K ﹤0.01%
327
-7
-2% -$73
QGEN icon
725
Qiagen
QGEN
$8.53B
$3K ﹤0.01%
58

Similar funds

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.